Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L

Cancer stem cells (CSCs) possess many characteristics associated with stem cells and are believed to drive tumor initiation. Although targeting of CSCs offers great promise for the new generation of therapeutics, lack of the effective drugable target and appropriate pharmacological reagents signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Chengli, Xu, Qiang, Jiang, Kui, Zhou, Guangyu, Yu, Xuebin, Wang, Lina, Zhu, Yuting, Fang, Liping, Yu, Zhe, Lee, Jiing-Dwan, Yu, Shi-Cang, Yang, Qingkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741765/
https://www.ncbi.nlm.nih.gov/pubmed/26432836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741765/
https://www.ncbi.nlm.nih.gov/pubmed/26432836

Ejemplares similares